HSI (OTC Pink: VRTY) is Leading the Paradigm Shift of Testing Patients With Opioid Alternatives for Pain Management
NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Healthcare Solutions Holdings Inc. (OTC Pink:VRTY), a medical service and...
NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Healthcare Solutions Holdings Inc. (OTC Pink:VRTY), a medical service and...
EDISON, NJ / ACCESSWIRE / December 10, 2019 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic...
OTTAWA, ON / ACCESSWIRE / December 10, 2019 / "The revised Intellectual Property Provisions negotiated as part of the Canada US...
PHILADELPHIA, PA / ACCESSWIRE / December 10, 2019 / NanoVibronix, Inc. (NASDAQ:NAOV), will be presenting at this year's Investor Summit...
THOROFARE, NJ / ACCESSWIRE / December 10, 2019 / Akers Biosciences, Inc. (NASDAQ:AKER), will be presenting at this year's Investor...
Sunrise™ Acute Care, Sunrise™ Revenue Cycle, Sunrise™ Radiology, Sunrise™ HIM Sunrise™ Pharmacy now deployed, as well Allscripts patient engagement platform,...
Funds to Fuel Commercialization of Breakthrough Technologies in Stroke Care to Enable Improved Patient Outcomes CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc....
ORLANDO, Fla / ACCESSWIRE / December 10, 2019 / Sharon H. Hrynkow, Ph.D., Chief Scientific Officer of Cyclo Therapeutics (OTCQB:...
Company Anticipates No Impact on FY 2019 Revenue, Adjusted EBITDA or Cash Flow Third Quarter 2019 Earnings to Be Announced...
EDISON, NJ / ACCESSWIRE / December 9, 2019 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development...
Correction: the name has been updated to Antonio Rozier, M.D. NEW YORK, NY / ACCESSWIRE / December 9, 2019 /...
MINNEAPOLIS--(BUSINESS WIRE)--LogicStream Health, a leading clinical process improvement and control software provider supporting hundreds of hospitals nationwide, introduced new software...
Using surveillance technology to predict risk of C. diff, hospitals can reduce time to detection and treatment to improve outcomes...
NIJMEGEN, THE NETHERLANDS / ACCESSWIRE / December 9, 2019 / Xenikos B.V.: 75% (9/12) patients achieved clinical response by day...
TAMPA, FL / ACCESSWIRE / December 9, 2019 / Advanzeon Solutions, Inc. (OTC PINK:CHCR)("Advanzeon") announced today that its wholly-owned subsidiary,...
HACKENSACK, NJ / ACCESSWIRE / December 9, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research...
VANCOUVER, BC, ACCESSWIRE / December 9, 2019 / Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces, further...
SHELTON, CT / ACCESSWIRE / December 9, 2019 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in nanomedicines...
NEW YORK, NY / ACCESSWIRE / December 9, 2019 / Veriheal has taken the U.S. by storm as an innovative...
Pre-clinical and clinical data demonstrate synergies between pelareorep and the proteasome inhibitor carfilzomib through inflammation, apoptosis and tumor responses Data...